Bowel Preparation in Colonoscopy: Lactulose vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study.
| 対象疾患 | Colorectal Cancer Screening |
|---|---|
| 相 | 第4相 |
| スポンサー | Hospital Civil de Guadalajara |
| ステータス | 完了 |
| 参加者数 | 449 名 |
| 介入（薬剤） | Bowel preparation before colonoscopy, Bowel preparation before colonoscopy |
| 開始日 | 2024年7月20日 |
| 完了日 | 2025年7月31日 |
| 結果公開日 | 2026年7月28日 |
概要
The goal of this clinical trial it is to bowel the instestinal preparation with lactulose vs poliethylenglicol as better agent to have a quality colonoscopy and demostrate that lactulose is most efective, has a good tolerance and the patient would have a better satisfaction, so the question is: wich is the eficancy of lactulose in comparision with thepoliethylenglycol in the intestinal preparation for the colonoscopy?
Bowel Cleansing Was Assessed Using the Boston Bowel Preparation Scale (BBPS).
| Bowel Preparation With Lactulose Before de Colonoscopy | 7.21 ± 1.61 Score scale |
|---|---|
| Bowel Preparation With Plyethylenglycol Before the Colonoscopy | 7.08 ± 1.49 Score scale |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- CryoBalloon Ablation for Treatment of Duodenal Adenomas — Johns Hopkins University
- Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refract — Jennerex Biotherapeutics
- Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III — National Cancer Institute (NCI)
- Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps — National Cancer Institute (NCI)
- Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal — National Cancer Institute (NCI)
- Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating — National Cancer Institute (NCI)